Article

An analysis of the global burden of pancreatic cancer attributable to High fasting plasma glucose: 1990– 2021

2025-07-25

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Pancreatic cancer (PC), a highly aggressive malignancy with poor prognosis, is frequently diagnosed at advanced stages. High fasting plasma glucose (HFPG), a key metabolic risk factor, significantly contributes to pancreatic cancer mortality and disability-adjusted life years (DALYs). This study aimed to quantify the global burden of pancreatic cancer attribu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d191dd42-0e30-540a-be6f-726af96c1d95
DOI: 10.21203/rs.3.rs-7063506/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An analysis of the global burden of pancreatic cancer attributable to High fasting plasma glucose: 1990– 2021DOI 10.21203/rs.3.rs-7063506/v1Read

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read

Demographics and epidemiology of pancreatic cancer.Semantic proximity Read

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithmsSemantic proximity Read

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithmsSemantic proximity Read

Epidemiology of pancreatic cancer: an update.Semantic proximity Read

Risk factors for pancreatic cancerSemantic proximity Read

An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.Semantic proximity Read

The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC.Semantic proximity Read

Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer.Semantic proximity Read

Serum gamma-glutamyl transferase level is associated with the risk of pancreatic cystic neoplasms: A nationwide cohort studySemantic proximity Read

Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohortSemantic proximity Read

Fatty Pancreas as a Marker of Tumor Dissemination in Pancreatic Cancer: A Systematic Review and Meta-analysisSemantic proximity Read